Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Lung Cancer

Free Subscription Articles published in Ann Surg Oncol Retrieve available abstracts of 42 articles: HTML format Text format

Single Articles

August 2019
1. SHINOHARA S, Otsuki R, Kobayashi K, Matsuo M, et al
   The Prognostic Impact of Pericardial Fat Volumes in Resected Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2019 Aug 12. pii: 10.1245/s10434-019-07703.
   PubMed     Text format     Abstract available
   
   
   July 2019
2. LEE JH, Shin KM, Lee SY, Hong MJ, et al
   Genetic Variant of Notch Regulator DTX1 Predicts Survival After Lung Cancer Surgery.
   Ann Surg Oncol. 2019 Jul 16. pii: 10.1245/s10434-019-07614.
   PubMed     Text format     Abstract available
   
   
   May 2019
3. XIE HJ, Zhang X, Mo YX, Long H, et al
   Tumor Volume Is Better Than Diameter for Predicting the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
   Ann Surg Oncol. 2019 May 3. pii: 10.1245/s10434-019-07412.
   PubMed     Text format     Abstract available
   
   
   
4. AKAMINE T, Tagawa T, Ijichi K, Toyokawa G, et al
   The Significance of CD44 Variant 9 in Resected Lung Adenocarcinoma: Correlation with Pathological Early-Stage and EGFR Mutation.
   Ann Surg Oncol. 2019;26:1544-1551.
   PubMed     Text format     Abstract available
   
   
   
5. BEANE JD, Wilson GC, Sutton JM, Shuai Y, et al
   Pleuropulmonary Recurrence Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Appendiceal Pseudomyxoma Peritonei.
   Ann Surg Oncol. 2019;26:1429-1436.
   PubMed     Text format     Abstract available
   
   
   April 2019
6. REINERSMAN JM
   Better Survival After 4L Lymph Node Dissection for Early-Stage, Left-Sided, Non-small Cell Lung Cancer: Are We Debating a False Duality?
   Ann Surg Oncol. 2019 Apr 23. pii: 10.1245/s10434-019-07382.
   PubMed     Text format    
   
   
   
7. ZHAO K, Wei S, Mei J, Guo C, et al
   Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer: Once Neglected But of Great Importance.
   Ann Surg Oncol. 2019 Apr 22. pii: 10.1245/s10434-019-07368.
   PubMed     Text format     Abstract available
   
   
   March 2019
8. ZENG Y, Mayne N, Yang CJ, D'Amico TA, et al
   A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer.
   Ann Surg Oncol. 2019 Mar 21. pii: 10.1245/s10434-019-07318.
   PubMed     Text format     Abstract available
   
   
   
9. PASTORINO U, Morelli D, Leuzzi G, Rolli L, et al
   Baseline and Postoperative C-reactive Protein Levels Predict Long-Term Survival After Lung Metastasectomy.
   Ann Surg Oncol. 2019;26:869-875.
   PubMed     Text format     Abstract available
   
   
   January 2019
10. LIN MW, Huang YL, Yang CY, Kuo SW, et al
    The Differences in Clinicopathologic and Prognostic Characteristics Between Surgically Resected Peripheral and Central Lung Squamous Cell Carcinoma.
    Ann Surg Oncol. 2019;26:217-229.
    PubMed     Text format     Abstract available
    
    
    
11. KAWAGUCHI Y, Hanaoka J, Ohshio Y, Okamoto K, et al
    Patient Survival after Surgical Management in Intrathoracic Pseudomyxoma peritonei.
    Ann Surg Oncol. 2019;26:238-243.
    PubMed     Text format     Abstract available
    
    
    December 2018
12. MEHTSUN WT, Chipidza FE, Fernandez-Del Castillo C, Hemingway K, et al
    Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma?
    Ann Surg Oncol. 2018;25:3936-3942.
    PubMed     Text format     Abstract available
    
    
    
13. REN Y, Zhang L, Xie H, She Y, et al
    Lymph Node Micrometastasis Prognosticates Survival for Patients with Stage 1 Bronchogenic Adenocarcinoma.
    Ann Surg Oncol. 2018;25:3812-3819.
    PubMed     Text format     Abstract available
    
    
    November 2018
14. OKADA S, Shimada J, Kato D, Tsunezuka H, et al
    Long-Term Prognostic Impact of Severe Postoperative Complications After Lung Cancer Surgery.
    Ann Surg Oncol. 2018 Nov 19. pii: 10.1245/s10434-018-7061.
    PubMed     Text format     Abstract available
    
    
    
15. TOYOSHIMA Y, Hara T, Matsui Y, Nagumo Y, et al
    Nodule Size After Chemotherapy and Primary-Tumor Teratoma Components Predict Malignancy of Residual Pulmonary Nodules in Metastatic Nonseminomatous Germ Cell Tumor.
    Ann Surg Oncol. 2018;25:3668-3675.
    PubMed     Text format     Abstract available
    
    
    
16. SAFFARZADEH AG, Blasberg JD
    Beyond TNM: Searching for New Patient-Centric Prognostic Indicators in NSCLC.
    Ann Surg Oncol. 2018;25:3425-3426.
    PubMed     Text format    
    
    
    October 2018
17. OKADA S, Inoue M
    ASO Author Reflections: Prognostic Nutritional Index-Based Risk Stratification for Lung Cancer.
    Ann Surg Oncol. 2018 Oct 10. pii: 10.1245/s10434-018-6884.
    PubMed     Text format    
    
    
    
18. LEE SY, Park JY
    GLUT1 Variants for Predicting Prognosis After Surgery in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Oct 3. pii: 10.1245/s10434-018-6847.
    PubMed     Text format    
    
    
    
19. YAMAGUCHI S, Morita M, Yamamoto M, Egashira A, et al
    Long-Term Outcome of Definitive Chemoradiotherapy and Induction Chemoradiotherapy Followed by Surgery for T4 Esophageal Cancer with Tracheobronchial Invasion.
    Ann Surg Oncol. 2018;25:3280-3287.
    PubMed     Text format     Abstract available
    
    
    
20. MALGRAS B, Gayat E, Aoun O, Lo Dico R, et al
    Impact of Combination Chemotherapy in Peritoneal Mesothelioma Hyperthermic Intraperitoneal Chemotherapy (HIPEC): The RENAPE Study.
    Ann Surg Oncol. 2018;25:3271-3279.
    PubMed     Text format     Abstract available
    
    
    September 2018
21. TAKAMORI S, Toyokawa G
    Sarcopenia After Resection of Early Non-small Cell Lung Cancer: Is Postoperative Skeletal Muscle Loss a Risk Factor for Poor Outcomes?
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6784.
    PubMed     Text format    
    
    
    
22. CLEMENT-DUCHENE C
    ASO Author Reflections: Survival Impact of N2 in Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Sep 22. pii: 10.1245/s10434-018-6779.
    PubMed     Text format    
    
    
    
23. LI X, Qin S, Sun X, Liu D, et al
    Prognostic Significance of Albumin-Globulin Score in Patients with Operable Non-Small-Cell Lung Cancer.
    Ann Surg Oncol. 2018 Sep 18. pii: 10.1245/s10434-018-6715.
    PubMed     Text format     Abstract available
    
    
    
24. ARNDT AT
    A Little Bit of Cancer is Still Cancer: Is it Time for Lymph Node Micrometastases in Non-small Cell Lung Cancer to Get Their Due?
    Ann Surg Oncol. 2018 Sep 10. pii: 10.1245/s10434-018-6747.
    PubMed     Text format    
    
    
    August 2018
25. LIANG RB, Yang J, Zeng TS, Long H, et al
    Incidence and Distribution of Lobe-Specific Mediastinal Lymph Node Metastasis in Non-small Cell Lung Cancer: Data from 4511 Resected Cases.
    Ann Surg Oncol. 2018 Aug 6. pii: 10.1245/s10434-018-6394.
    PubMed     Text format     Abstract available
    
    
    July 2018
26. DO SK, Jeong JY, Lee SY, Choi JE, et al
    Glucose Transporter 1 Gene Variants Predict the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Jul 30. pii: 10.1245/s10434-018-6677.
    PubMed     Text format     Abstract available
    
    
    June 2018
27. OKAMOTO T, Takada K, Sato S, Toyokawa G, et al
    Clinical and Genetic Implications of Mutation Burden in Squamous Cell Carcinoma of the Lung.
    Ann Surg Oncol. 2018;25:1564-1571.
    PubMed     Text format     Abstract available
    
    
    April 2018
28. AMIT M, Tam S, Abdelmeguid AS, Kupferman ME, et al
    Patterns of Treatment Failure in Patients with Sinonasal Mucosal Melanoma.
    Ann Surg Oncol. 2018 Apr 6. pii: 10.1245/s10434-018-6465.
    PubMed     Text format     Abstract available
    
    
    March 2018
29. KRANTZ SB
    Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2018 Mar 26. pii: 10.1245/s10434-018-6441.
    PubMed     Text format    
    
    
    February 2018
30. MORENO AC, Haque W, Verma V, Fang P, et al
    Concurrent Versus Sequential Chemoradiation Therapy in Completely Resected Pathologic N2 Non-Small Cell Lung Cancer: Propensity-Matched Analysis of the National Cancer Data Base.
    Ann Surg Oncol. 2018 Feb 26. pii: 10.1245/s10434-018-6399.
    PubMed     Text format     Abstract available
    
    
    
31. OKADA S, Shimada J, Teramukai S, Kato D, et al
    Risk Stratification According to the Prognostic Nutritional Index for Predicting Postoperative Complications After Lung Cancer Surgery.
    Ann Surg Oncol. 2018 Feb 15. pii: 10.1245/s10434-018-6368.
    PubMed     Text format     Abstract available
    
    
    
32. CLEMENT-DUCHENE C, Luc A, Casse JM, Vignaud JM, et al
    Survival Impact of Stations of Pathological Lymph Nodes in N2 Non-small Cell Lung Cancer in a French Hospital.
    Ann Surg Oncol. 2018 Feb 14. pii: 10.1245/s10434-018-6373.
    PubMed     Text format     Abstract available
    
    
    
33. JIN K, Wang K, Zhang H, Pan Y, et al
    Solitary Pulmonary Lesion in Patients with History of Malignancy: Primary Lung Cancer or Metastatic Cancer?
    Ann Surg Oncol. 2018 Feb 7. pii: 10.1245/s10434-018-6360.
    PubMed     Text format     Abstract available
    
    
    January 2018
34. RENAUD S, Seitlinger J, Guerrera F, Reeb J, et al
    Prognostic Value of Exon 19 Versus 21 EGFR Mutations Varies According to Disease Stage in Surgically Resected Non-small Cell Lung Cancer Adenocarcinoma.
    Ann Surg Oncol. 2018 Jan 23. pii: 10.1245/s10434-018-6347.
    PubMed     Text format     Abstract available
    
    
    
35. TAKAMORI S, Toyokawa G, Okamoto T, Shimokawa M, et al
    Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2018 Jan 11. pii: 10.1245/s10434-017-6328.
    PubMed     Text format     Abstract available
    
    
    November 2017
36. HENNON M, Sahia R, Yendamuri S, Demmy T, et al
    Video-Assisted Thoracic Surgery for Patients with Advanced-Stage Non-small Cell Lung Cancer: A Reply.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6233.
    PubMed     Text format    
    
    
    
37. FUNAI K
    Can Vessel Invasion Change the TNM Stage in Non-small Cell Lung Cancer? A Reply.
    Ann Surg Oncol. 2017 Nov 27. pii: 10.1245/s10434-017-6246.
    PubMed     Text format    
    
    
    
38. CAO C, Yan TD, He J
    Video-Assisted Thoracic Surgery for Patients with Advanced Stage Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Nov 20. doi: 10.1245/s10434-017-6232.
    PubMed     Text format    
    
    
    August 2017
39. SONG Z, Ye T, Ma L, Xiang J, et al
    Surgical Outcomes of Isolated Malignant Pulmonary Nodules in Patients with a History of Breast Cancer.
    Ann Surg Oncol. 2017 Aug 28. doi: 10.1245/s10434-017-6067.
    PubMed     Text format     Abstract available
    
    
    
40. SEOK Y, Kang HG, Lee SY, Jeong JY, et al
    Polymorphisms in Epithelial-Mesenchymal Transition-Related Genes and the Prognosis of Surgically Treated Non-small Cell Lung Cancer.
    Ann Surg Oncol. 2017 Aug 1. doi: 10.1245/s10434-017-6002.
    PubMed     Text format     Abstract available
    
    
    June 2016
41. ANDTBACKA RH, Ross M, Puzanov I, Milhem M, et al
    Patterns of Clinical Response with Talimogene Laherparepvec (T-VEC) in Patients with Melanoma Treated in the OPTiM Phase III Clinical Trial.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    
    
42. PATEL D, Townsend AR, Karapetis C, Beeke C, et al
    Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry.
    Ann Surg Oncol. 2016.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: